Ascendis Pharma A/S (ASND)
253.38
+1.43
(+0.57%)
USD |
NASDAQ |
Aug 25, 16:00
253.38
0.00 (0.00%)
After-Hours: 19:59
Ascendis Pharma Total Assets (Quarterly) : 2.614B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.614B |
| March 31, 2026 | 2.308B |
| December 31, 2025 | 1.530B |
| September 30, 2025 | 1.357B |
| June 30, 2025 | 1.277B |
| March 31, 2025 | 1.147B |
| December 31, 2024 | 1.221B |
| September 30, 2024 | 1.221B |
| June 30, 2024 | 812.71M |
| March 31, 2024 | 866.70M |
| December 31, 2023 | 911.98M |
| September 30, 2023 | 924.51M |
| June 30, 2023 | 898.79M |
| March 31, 2023 | 1.050B |
| December 31, 2022 | 1.163B |
| September 30, 2022 | 1.248B |
| June 30, 2022 | 1.387B |
| March 31, 2022 | 1.532B |
| December 31, 2021 | 1.234B |
| September 30, 2021 | 1.397B |
| June 30, 2021 | 1.010B |
| March 31, 2021 | 1.135B |
| December 31, 2020 | 1.199B |
| September 30, 2020 | 1.227B |
| June 30, 2020 | 629.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 681.84M |
| December 31, 2019 | 759.63M |
| September 30, 2019 | 801.25M |
| June 30, 2019 | 873.64M |
| March 31, 2019 | 855.54M |
| December 31, 2018 | 364.63M |
| September 30, 2018 | 389.37M |
| June 30, 2018 | 430.67M |
| March 31, 2018 | 448.68M |
| December 31, 2017 | 253.34M |
| September 30, 2017 | 262.50M |
| June 30, 2017 | 162.42M |
| March 31, 2017 | 184.78M |
| December 31, 2016 | 200.48M |
| September 30, 2016 | 97.49M |
| June 30, 2016 | 114.13M |
| March 31, 2016 | 128.40M |
| December 31, 2015 | 143.15M |
| September 30, 2015 | 157.68M |
| June 30, 2015 | 165.03M |
| March 31, 2015 | |
| December 31, 2014 | 70.99M |
| September 30, 2014 | 19.87M |
| June 30, 2014 | 27.55M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Evaxion AS | 19.38M |
| Genmab A/S | 12.51B |
| Zealand Pharma A/S | 3.023B |
| Cellectis SA | 267.36M |
| BioMarin Pharmaceutical, Inc. | 11.72B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 971.27M |
| Shareholders Equity (Quarterly) | 1.642B |
| Debt to Equity Ratio | 0.3133 |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | 0.46% |